To determine if TGFβ- and activin-induced migration involves MEK/ERK or PI3K signaling respectively, we inhibited PI3K or MEK in our colon cancer cell models and assessed the impact on migration following ligand stimulation. The gene discussed is MAP2K7; the disease is colonic neoplasm.